[HTML][HTML] Biological basis for novel mesothelioma therapies
Mesothelioma is an aggressive cancer that is associated with exposure to asbestos.
Although asbestos is banned in several countries, including the UK, an epidemic of …
Although asbestos is banned in several countries, including the UK, an epidemic of …
Biological basis for novel mesothelioma therapies
J Obacz, H Yung, M Shamseddin… - British Journal of …, 2021 - discovery.ucl.ac.uk
Mesothelioma is an aggressive cancer that is associated with exposure to asbestos.
Although asbestos is banned in several countries, including the UK, an epidemic of …
Although asbestos is banned in several countries, including the UK, an epidemic of …
Biological basis for novel mesothelioma therapies
J Obacz, H Yung, M Shamseddin, E Linnane… - British Journal of …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Mesothelioma is an aggressive cancer that is
associated with exposure to asbestos. Although asbestos is banned in several countries …
associated with exposure to asbestos. Although asbestos is banned in several countries …
[PDF][PDF] Biological basis for novel mesothelioma therapies
J Obacz, H Yung, M Shamseddin, E Linnane, X Liu… - 2021 - core.ac.uk
BACKGROUND Mesothelioma is a malignancy primarily of the thoracic and abdominal
linings that affects 2600 individuals in the UK annually with a median survival of about 1 …
linings that affects 2600 individuals in the UK annually with a median survival of about 1 …
[HTML][HTML] Biological basis for novel mesothelioma therapies
J Obacz, H Yung, M Shamseddin, E Linnane… - British Journal of …, 2021 - ncbi.nlm.nih.gov
Mesothelioma is an aggressive cancer that is associated with exposure to asbestos.
Although asbestos is banned in several countries, including the UK, an epidemic of …
Although asbestos is banned in several countries, including the UK, an epidemic of …
Biological basis for novel mesothelioma therapies.
J Obacz, H Yung, M Shamseddin, E Linnane… - British Journal of …, 2021 - europepmc.org
Mesothelioma is an aggressive cancer that is associated with exposure to asbestos.
Although asbestos is banned in several countries, including the UK, an epidemic of …
Although asbestos is banned in several countries, including the UK, an epidemic of …
Biological basis for novel mesothelioma therapies
J Obacz, H Yung, M Shamseddin, E Linnane, X Liu… - 2021 - repository.cam.ac.uk
Mesothelioma is an aggressive cancer that is associated with exposure to asbestos.
Although asbestos is banned in several countries, including the UK, an epidemic of …
Although asbestos is banned in several countries, including the UK, an epidemic of …
Biological basis for novel mesothelioma therapies
J Obacz, H Yung, M Shamseddin… - British journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Mesothelioma is an aggressive cancer that is associated with exposure to asbestos.
Although asbestos is banned in several countries, including the UK, an epidemic of …
Although asbestos is banned in several countries, including the UK, an epidemic of …
[PDF][PDF] Biological basis for novel mesothelioma therapies
J Obacz, H Yung, M Shamseddin, E Linnane, X Liu… - 2021 - scienceopen.com
BACKGROUND Mesothelioma is a malignancy primarily of the thoracic and abdominal
linings that affects 2600 individuals in the UK annually with a median survival of about 1 …
linings that affects 2600 individuals in the UK annually with a median survival of about 1 …
Biological basis for novel mesothelioma therapies.
J Obacz, H Yung, M Shamseddin, E Linnane, X Liu… - 2021 - repository.cam.ac.uk
Mesothelioma is an aggressive cancer that is associated with exposure to asbestos.
Although asbestos is banned in several countries, including the UK, an epidemic of …
Although asbestos is banned in several countries, including the UK, an epidemic of …